chr2-238848438-G-A
Variant summary
Our verdict is Pathogenic. The variant received 17 ACMG points: 17P and 0B. PM2PM5PP2PP3_StrongPP5_Very_Strong
The NM_001271893.4(TWIST2):c.223G>A(p.Glu75Lys) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 13/22 in silico tools predict a damaging outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. E75A) has been classified as Pathogenic.
Frequency
Consequence
NM_001271893.4 missense
Scores
Clinical Significance
Conservation
Publications
- ablepharon macrostomia syndromeInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, G2P, Labcorp Genetics (formerly Invitae)
- Barber-Say syndromeInheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae)
- focal facial dermal dysplasia type IIIInheritance: AD, AR Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), G2P
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 17 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| TWIST2 | NM_001271893.4 | c.223G>A | p.Glu75Lys | missense_variant | Exon 1 of 2 | ENST00000612363.2 | NP_001258822.1 | |
| TWIST2 | NM_057179.3 | c.223G>A | p.Glu75Lys | missense_variant | Exon 1 of 2 | NP_476527.1 | ||
| TWIST2 | XR_007069137.1 | n.354G>A | non_coding_transcript_exon_variant | Exon 1 of 2 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| TWIST2 | ENST00000612363.2 | c.223G>A | p.Glu75Lys | missense_variant | Exon 1 of 2 | 1 | NM_001271893.4 | ENSP00000482581.1 | ||
| TWIST2 | ENST00000448943.2 | c.223G>A | p.Glu75Lys | missense_variant | Exon 1 of 2 | 1 | ENSP00000405176.2 | |||
| TWIST2 | ENST00000710607.1 | c.223G>A | p.Glu75Lys | missense_variant | Exon 1 of 2 | ENSP00000518373.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Data not reliable, filtered out with message: AS_VQSR AF: 7.17e-7 AC: 1AN: 1395318Hom.: 0 Cov.: 31 AF XY: 0.00000145 AC XY: 1AN XY: 689052 show subpopulations ⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Ablepharon macrostomia syndrome Pathogenic:3
A heterozygous missense p.Glu75Lys was reported to be associated with Ablepharon macrostomia syndrome in 7 families (Marchegiani et al. 2015). This variant was not found in ExAC database and our in-house Thai exome database (consisted of 1084 Thai exome controls). We classified this as pathogenic variant by ACMG Guidelines, 2015 based on >/=2 strong criteria [PS1, PS2, and PS3 (Functional study by Marchegiani et al. 2015)].
This variant is classified as Pathogenic. Evidence in support of pathogenic classification: Variant is present in gnomAD <0.01 (v4: 1 heterozygote(s), 0 homozygote(s)) ; This variant has strong previous evidence of pathogenicity in unrelated individuals. This variant has been reported in individuals with ablepharon macrostomia syndrome (AMS), including multiple de novo occurrences (PMID: 26119818), and has been classified as pathogenic by clinical laboratories (ClinVar); Other missense variants comparable to the one identified in this case have very strong previous evidence for pathogenicity. The p.(Glu75Gln) and p.(Glu75Ala) variants have been reported in individuals with Barber-Say syndrome (BSS), including de novo occurrences (PMID: 26119818), and have been classified as pathogenic by clinical laboratories (ClinVar); Variant is located in a hotspot region or cluster of PATHOGENIC variants. Multiple recurrent missense variants associated with AMS or BSS have been reported at this amino acid residue (PMID: 26119818); Missense variant predicted to be damaging by in silico tool(s) or highly conserved with a major amino acid change; Strong phenotype match for this individual; This variant has been shown to be de novo in the proband by trio analysis (parental status confirmed). Additional information: Variant is predicted to result in a missense amino acid change from Glu to Lys; This variant is heterozygous; This gene is associated with both recessive and dominant disease. Monoallelic variants in this gene have been reported in individuals with ablepharon-macrostomia syndrome (MIM#200110), and Barber-Say syndrome (MIM#209885). Biallelic variants have been reported in individuals with Setleis syndrome (MIM#227260); Dominant negative and loss of function are reported mechanisms of disease in this gene. Heterozygous variants in TWIST2 are reported to have a dominant-negative effect in individuals with AMS and BSS (PMID: 28369379), whereas biallelic loss of function variants are reported to cause Setleis syndrome (PMID: 20691403).
Inborn genetic diseases Pathogenic:1
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at